Exclusive: NHS must keep medicine clawback down or lose investment, says weight-jab boss

The NHS must keep its medicines clawback tax low and predictable or else risk disrupting the rollout of weight-loss drugs in the UK, Novo Nordisk’s UK chief has said. Sebnem Avsar Tuna, general manager of UK operations for the Ozempic and Wegovy maker, told City AM the Government must keep in place the current ceiling [...]